Pacitti David 4

What Happened David Pacitti, a director of Orchestra BioMed Holdings, Inc. (OBIO), received equity awards on June 23, 2026: 17,327 restricted stock units (RSUs) and a 21,277-share derivative award (stock-option type). All awards show $0.00 per-share acquisition price in the filing. On June 24, 2026 the issuer withheld 3,784 shares to satisfy tax withholding obligations related to RSU vesting; no shares were sold in the open market.

Key Details

• Transaction dates: Grants dated 2026-06-23; withholding dated 2026-06-24. Filing date: 2026-06-25 (appears timely — within the typical 2-business-day Form 4 window).
• Prices: All entries reported at $0.00 (award/grant form of compensation).
• Shares acquired: 17,327 RSUs (award) + 21,277 derivative award units (stock options).
• Shares withheld/disposed: 3,784 shares withheld by the issuer to satisfy tax withholding (no market sale).
• Shares owned after transaction: Not reported in the provided filing details.
• Footnotes of note:
  • F1: RSUs represent rights to one share each and vest on the one-year anniversary of the grant, subject to continuous service.
  • F2: Withholding was done by the issuer to cover taxes; no open-market sale occurred.
  • F3: The derivative (stock option) awards will vest on the one-year anniversary, subject to continuous service.

Context These are compensation-related grants (an award), not open-market purchases or sales; such awards are routine for directors and are tied to future vesting/service. The RSUs and options vest in one year if the reporting person remains in service, and the withholding simply satisfied tax obligations rather than reflecting a sale.